Exact Sciences, US30063P1057

Exact Sciences stock heads into the open after Nasdaq gains

Published on 09/23/2026 at 05:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Exact Sciences stock is measured against a Nasdaq Composite that added 0.45 percent to 27,244.28, setting a record close.

Wissenschaftlerinnen analysieren Krebsproben in einem modernen Diagnostiklabor von Exact Sciences
Exact Sciences Corp. betreibt hochmoderne Labore für die molekulare Krebsfrüherkennung weltweit ISIN US30063P1057, Illustration mit AI erstellt.

Exact Sciences stock closed at USD 41.62 on the Nasdaq on September 22, 2026, down 0.24 percent. The Nasdaq Composite gained 0.45 percent to 27,244.28, making the stock a relative laggard in the same session.

September 22, 2026 in numbers

Exact Sciences Inc. (ISIN US30063P1057) traded between USD 41.31 and USD 42.08 before ending at USD 41.62 on the Nasdaq. Volume reached 1,821,437 shares, while the Nasdaq Composite closed at 27,244.28, up 0.45 percent on September 22, 2026.

September 23, 2026 outlook

The broader US market enters the session after the Nasdaq Composite recorded a 0.45 percent gain on September 22, 2026. Reuters reported that retreating oil prices supported risk appetite as technology shares recovered.

Disclaimer...

en | US30063P1057 | EXACT SCIENCES | boerse | 70162186 | bgmi